Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - OPERATING INCOME
Operating Income ALNY - Alnylam Pharmaceuticals, Inc.
-177 M
LAST VALUE
52.53%
2 YEAR CAGR
28.39%
5 YEAR CAGR
7.95%
10 YEAR CAGR